Your browser doesn't support javascript.
loading
D-dimer assay interference detected by the discrepancy in D-dimer concentrations at different dilutions: a case report.
Milic, Marija; Brkic Barbaric, Dejana; Lukic, Iva; Kirin, Mirna; Buljanovic, Vikica; Seric, Vatroslav.
Afiliação
  • Milic M; Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
  • Brkic Barbaric D; Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.
  • Lukic I; Clinical Institute of Transfusion Medicine, University Hospital Centre Osijek, Osijek, Croatia.
  • Kirin M; Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
  • Buljanovic V; Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.
  • Seric V; Siemens Healthineers, Siemens Healthcare d.o.o, Zagreb, Croatia.
Biochem Med (Zagreb) ; 34(3): 031001, 2024 Oct 15.
Article em En | MEDLINE | ID: mdl-39171087
ABSTRACT
This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos de Degradação da Fibrina e do Fibrinogênio / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos de Degradação da Fibrina e do Fibrinogênio / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article